ABSTRACT Local anesthetics such as dibucaine, QX572, tetracaine, and phenacaine, as well as other drugs with local anesthetic-like properties (e.g., mepacrine, propranolol, and SKF 525A) inhibit the specific calmodulin-dependent stimulation of erythrocyte Ca2+-ATPase (ATP phosphohydrolase, EC 3.6
ABSTRACT Local anesthetics such as dibucaine, QX572, tetracaine, and phenacaine, as well as other drugs with local anesthetic-like properties (e.g., mepacrine, propranolol, and SKF 525A) inhibit the specific calmodulin-dependent stimulation of erythrocyte Ca2+-ATPase (ATP phosphohydrolase, EC 3.6.1.3) and cyclic nucleotide phosphodiesterases (3',5'-cyclic-nucleotide 5'-nucleotidohydrolase, EC 3.1.4.17) from brain and heart. Basal activities of these enzymes in the absence of calmodulin are relatively unaffected by concentrations of local anesthetics that strongly inhibit the specific stimulation by calmodulin. Increasing calmodulin, but not Ca2+, overcomes the inhibitory action of the local anesthetics on brain phosphodiesterase. However excess calmodulin does not fully restore activity oferythrocyte Ca1+-stimulated ATPase. Although the mechanism(s) by which the local anesthetics act is unclear, they inhibit binding of '25I-labeled calmodulin to the erythrocyte membrane. Antagonism of calmodulin provides a molecular mechanism that may explain the inhibition of many Ca2+-dependent cellular processes by local anestheticse.g., Ca2+ transport, exocytosis, excitation-contraction coupling, non-muscle-cell motility, and aggregation.
Local anesthetics are classified as such by their ability to block conduction of impulses in nerves reversibly. However, these drugs can also affect a wide range of cellular processes in nonnerve tissue, such as excitation-contraction coupling in various types of muscle (1, 2) , exocytosis (3) (4) (5) (6) , membrane transport or permeability of calcium (7) , glucose (8) , and anions (9) , cellular adhesion (10) or aggregation (11) , osmotic fragility (12) , and ligand-induced Ig receptor capping (13) . Several enzymatic activities are also affected by local anesthetics, notably response of adenylate cyclase to catecholamines (14) , Mg2+,Ca2+-dependent ATPases ofbrain (15) , sarcoplasmic reticulum (16) , and erythrocytes (17) , and phospholipase A2 (18) . Many ofthe effects of local anesthetics are manifested on calcium-dependent processes and have usually been attributed to influences on membrane calcium permeability or binding (19) .
In addition to effects of local anesthetics mediated by membrane pertubations we considered that antagonism of Ca2+-mediated processes might be due to effects on the actions of calmodulin. Calmodulin, a ubiquitous Ca2+-binding protein in eukaryotes, is one of the most important mediators ofcalcium's role as an intracellular messenger, affecting contractile proteins, cyclic nucleotide metabolism, glycogenolysis, phospholipid metabolism, membrane phosphorylation, and Ca2+ transport (20, 21) . We therefore undertook a study of the influence oflocal anesthetics on several calmodulin-dependent enzymatic reactions. In this paper we report on two such enzymes; Ca2+-ATPase (ATP phosphohydrolase, EC 3.6.1.3) of the erythrocyte membrane and cyclic nucleotide phosphodiesterase (3',5'-cyclic nucleotide 5'-nucleotidohydrolase, EC 3.1.4.17) from brain and cardiac muscle. Preliminary reports of these findings have been published (22, 23) .
METHODS AND MATERIALS
Preparation of Human Erythrocyte Membranes. Erythrocyte membranes were prepared by the method ofGopinath and Vincenzi (24) modified by carrying out hemolysis in 10 mM imidazole HCl, pH 7.4/1 mM EDTA. Aliquots (2.0 ml) of the membrane suspensions containing 1.0-1.7 mg of protein per ml were frozen in dry ice/acetone and stored at -800C.
Assay of Calcium ATPase. Calcium-stimulated ATPase activity in the membranes was measured by the radioisotope assay of Seals et al. (25) as described in the legend to Fig. 1 .
Purification of Erythrocyte Calmodulin. Calmodulin was purified according to the method of Jarrett and Penniston (26) through the Sephadex G-100 chromatography step. Active fractions were dialyzed against water, lyophilized, and redissolved in the minimal volume of 10 mM 1,4-piperazinediethanesulfonic acid at pH 6.5. Pure calmodulin was isolated by preparative discontinuous pH/polyacrylamide gel electrophoresis (27) . In 10.5% polyacrylamide, calmodulin migrated with the bromophenol blue dye front and was eluted from the gels into 0.1 M potassium phosphate, pH 6.6/1 mM ethylene glycol bis(f3-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA Klee) , indicating the presence of some residual endogenous calmodulin. Nevertheless, the enzyme could be markedly stimulated by the addition of exogenous calmodulin (Fig. 1) .
The degree of enhancement of ATPase activity depended upon the concentrations of both Ca2+ and calmodulin (Fig. 2) . Increasing calmodulin concentration increased the ATPase activity at the optimal Ca2' level. At high concentrations of calmodulin the sensitivity to calcium was increased so that activity was nearly maximal even at the lower calcium concentrations (Fig. 2C) . A similar effect of high calmodulin concentration on calcium sensitivity has been observed with heart phosphodiesterase (34) . Increasing calcium beyond the optimum resulted in a decreased ATPase activity independent of the calmodulin concentration, as also observed by Luthra and Kim (35) .
Several local anesthetics inhibited the stimulatory effect of calmodulin. The basal Mg2e,Ca2+-ATPase activity was not inhibited (or was only slightly inhibited, :15%) by anesthetic concentrations that strongly (>80%) antagonized the stimulation by calmodulin. Dibucaine shifted the concentration-response curves for the modulator protein (Fig. 1) . Increasing calmodulin tended to overcome the local anesthetic inhibition (Fig. 1 (Fig. 4) . Dibucaine produced a concentration-dependent inhibition of '"I-labeled calmodulin binding (Fig. 4) similar to the inhibition of Ca2+-ATPase activity under the same conditions (Fig. 3) The calmodulin stimulation of cyclic nucleotide phosphodiesterase from both rat brain and bovine heart was inhibited by -rsal of the local aneslocal anesthetics and drugs exhibiting local anesthetic properCa could not restore ties. In the presence of 0.5 mM dibucaine, the apparent Km of kTPase activity in the phosphodiesterase for calmodulin increased from 3.5 nM to ihibition of the rate of about 170 nM at 0.25 MM cyclic AMP and from 6 nM to about ne concentration (Fig. 400 nM at 1 AM cyclic GMP (Fig. 5) . Lineweaver-Burk analysis )ns ofcalmodulin (Fig. indicated that inhibition by dibucaine was competitive with relent at the approximate spect to calmodulin with a calculated KI of 8-10 MM. In a sep-(=1 ,M) in the intact arate experiment using higher concentrations ofcalmodulin, the inhibition of cyclic AMP hydrolysis by 0.5 mM dibucaine was esthetics inhibited the completely overcome at 1500 nM calmodulin. This is somewhat different from the particulate Ca2+-ATPase system in which inhibition by dibucaine was still apparent at this calmodulin concentration (Fig. 1 ). As observed with the Ca2+-ATPase system, inhibition ofphosphodiesterase by dibucaine could not be overcome by increasing calcium up to 1 mM.
Dibucaine had no effect on basal (minus calmodulin) phosphodiesterase activity at a concentration equal to its apparent Kj against calmodulin. Even at 0.5 mM dibucaine, which shifted the calmodulin dose-response curve =50-fold, the basal activity was inhibited by only 14%. At a constant calmodulin concentration (15 nM), the inhibition by dibucaine appeared to be noncompetitive with respect to cyclic AMP as substrate when analyzed by Lineweaver-Burk analysis. Inhibition of basal phosphodiesterase activity required much higher concentrations of dibucaine and appeared to be competitive with respect to substrate (K. =5 mM). Similarly, a calmodulin-insensitive, low-Kn phosphodiesterase purified from Kidney (29) was also inhibited by local anesthetics in a competitive manner with respect to substrate. Thus, local anesthetics had two effects: one at low concentrations directed against the effect of calmodulin and independent of substrate and Ca2' concentration, and the second at high concentrations affecting the affinity of the enzyme for substrate.
In addition to dibucaine, calmodulin stimulation of phosphodiesterase was inhibited by other local anesthetics and mepacrine, propranolol, and ,B diethylaminoethyl-2,2-diphenyl pentanoate (SKF 525A) ( Table 1 ). The action ofpropranolol was nonstereospecific and therefore was related to its local anesthetic-like properties rather than to its activity as a f3-adrenergic antagonist. The relative IC50 values for the inhibition of the phosphodiesterase were lower than those obtained for the inhibition ofthe Ca2+-ATPase (see above); however, the IC50 values for the brain enzyme were determined at 15 nM calmodulin (0.9-1.0 Vm. for phosphodiesterase activation), whereas those for the erythrocyte Ca2+-ATPase were determined at 66 nM calmodulin (0.9-1.0 Vm. for Ca2+-ATPase activation). Relative IC50 values may vary depending upon the concentration of calmodulin used.
DISCUSSION
The present results demonstrate that some local anesthetics and other drugs which act as calcium antagonists (12), such as mepacrine, propranolol, and SKF 525A, inhibit the stimulatory effect of calmodulin on enzymes with little or no effect on the activity of these enzymes in the absence of calmodulin. According to current models for the action of calmodulin, increased concentrations of Ca2+ or the modulator protein promote the formation of the Ca2+-calmodulin complex, which in turn shifts the equilibrium for an enzyme from the inactive to the active form (20, 21) . Calmodulin appears to be present in cells in excess of the concentration of the enzymes it affects so that cellular calcium fluxes would be most important for regulating enzyme activity. Phenothiazines bind to specific sites on the Ca2+-calmodulin complex with the result that the ternary complex is rendered ineffectual in activating enzymes (36) . Similarly, local anesthetics could make the concentration ofthe modulator protein rather than Ca2' the rate-limiting factor by inactivating calmodulin or by preventing binding ofcalmodulin to enzymes.
Local anesthetics inhibit the ability ofcalmodulin to stimulate two different types ofenzymes; one an integral membrane protein involved in transport of Ca2+, and the other a soluble enzyme concerned with cyclic nucleotide degradation. The action of the anesthetics is therefore not confined to membrane-dependent reactions.
The local anesthetics prevent binding of calmodulin to the erythrocyte membrane, producing a corresponding inhibition of ATPase activity. However, we have not as yet identified the site, or sites, of action of the local anesthetics as being on calmodulin itself [as has been postulated for phenothiazines (36) ], on the calmodulin recognition site of the enzyme, or on some other regulatory site.
We propose that many ofthe pharmacological actions oflocal anesthetics, which are directed against calcium-dependent cellular processes, may be due to antagonism of calmodulin's effects on enzymes because both the pharmacological effects and the inhibition ofcalmodulin in vitro occur at similar concentrations of these drugs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . For example, inhibition of Ca2+ transport in erythrocytes by local anesthetics (37) may be related to the need for calmodulin in the transport process (38) . Similarly, inhibition of smooth muscle contraction (2) and non-muscle cellular motility (10) by local anesthetics could be produced by inhibition ofcalmodulin-dependent myosin light chain phosphorylation (39) as observed with phenothiazines (40) . Also, inhibition of the mobilization of arachidonic acid from phospholipids by local anesthetics (41, 42) may be related to the reported stimulation ofphospholipase A2 by calmodulin (43) .
Antagonism ofcalmodulin could also be responsible for some ofthe actions oflocal anesthetics on synaptic transmission. Local anesthetics as well as trifluoperazine (44) 
